Cannabis Business Times Editor Theresa Bennett, Senior Editor Zach Mentz, Associate Editor Andriana Ruscitto, and Managing Editor Patrick Williams contributed to this report, which was originally published online Oct. 26, 2022. Read the original, extended version here.
During the past 50 years—and especially in the past decade, as more states legalized medical and adult-use cannabis consumption and sales—there have been several petitions, bills, resolutions and other pushes for the federal government to review cannabis’s Schedule I status in the Controlled Substances Act (CSA).
